Amanote Research
Register
Sign In
Treatment of Pure Red Cell Aplasia After Major ABO-incompatible Peripheral Blood Stem Cell Transplantation by Induction of Chronic Graft-Versus-Host Disease
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1703699
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
October 1, 2002
Authors
M Yamaguchi
K Sakai
R Murata
M Ueda
Publisher
Springer Science and Business Media LLC
Related search
Acute and Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
Revista da Associacao Medica Brasileira
Medicine
Pure Red Cell Aplasia After Kidney Transplantation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning
Bone Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia
American Journal of Hematology
Hematology
Enhancement of Cyclosporin A-Induced Autologous Graft-Versus-Host Disease After Peripheral Blood Stem Cell Transplantation by Utilizing Selected CD34+ Cells
Bone Marrow Transplantation
Transplantation
Hematology
Risk Assessment and Outcome of Chronic Graft-Versus-Host Disease After Allogeneic Peripheral Blood Progenitor Cell Transplantation in Pediatric Patients
Bone Marrow Transplantation
Transplantation
Hematology
Successful Treatment of Isohemagglutinin-Mediated Pure Red Cell Aplasia After ABO-mismatched Allogeneic Hematopoietic Cell Transplant Using Bortezomib
Bone Marrow Transplantation
Transplantation
Hematology
Demodocidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
Turkish Journal of Haematology
Hematology
Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab
American Journal of Hematology
Hematology
